GlassScriptPhysician profile
Rashna Ginwalla
NPI 1093962284
$3,526.66
in general payments reported to CMS, 2019-2025
8 companies · $1,635 in 2025
The $1,635 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.40 · 2021: $733 · 2022: $14.37 · 2023: $105 · 2024: $967 · 2025: $1,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,091 · Education: $1,000 · Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,090.65 |
| Education | $1,000.00 |
| Food and Beverage | $615.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,208.39 | 2024-2025 | Progrip, Signia |
| Intuitive Surgical, INC. | $1,082.79 | 2023-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $641.12 | 2021 | |
| W. L. Gore & Associates, INC. | $376.97 | 2025 | Gore Bio-A Tissue Reinforcement |
| Depuy Synthes Sales INC. | $91.48 | 2021 | |
| Medtronic USA, INC. | $73.40 | 2019 | |
| Ethicon US, LLC | $36.10 | 2022-2023 | Echelon Flex |
| Kls-Martin L.P. | $16.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashna Ginwalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.